Is Amazon an AI Stock?
With the market starting to look skittish on pure-play AI…
Buy
64
PJP Quote, Financials, Valuation and Earnings
Last price:
$105.06
Seasonality move
:
3.6%
Day range:
$104.76 - $105.55
52-week range:
$72.25 - $106.75
Dividend yield:
0.95%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
10.6K
Avg. volume:
13.7K
1-year change:
21.03%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
PJP
Invesco Pharmaceuticals ETF
|
-- | -- | -- | -- | -- |
|
FBT
First Trust NYSE Arca Biotechnology Index Fund
|
-- | -- | -- | -- | -- |
|
PBE
Invesco Biotechnology & Genome ETF
|
-- | -- | -- | -- | -- |
|
RSPH
Invesco S&P 500 Eql Wght Health Care ETF
|
-- | -- | -- | -- | -- |
|
XHE
State Street SPDR S&P Health Care Equipment ETF
|
-- | -- | -- | -- | -- |
|
XPH
State Street SPDR S&P Pharmaceuticals ETF
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
PJP
Invesco Pharmaceuticals ETF
|
$105.41 | -- | -- | -- | $0.24 | 0.95% | -- |
|
FBT
First Trust NYSE Arca Biotechnology Index Fund
|
$212.83 | -- | -- | -- | $1.17 | 0.55% | -- |
|
PBE
Invesco Biotechnology & Genome ETF
|
$82.11 | -- | -- | -- | $0.23 | 0.49% | -- |
|
RSPH
Invesco S&P 500 Eql Wght Health Care ETF
|
$31.90 | -- | -- | -- | $0.06 | 0.71% | -- |
|
XHE
State Street SPDR S&P Health Care Equipment ETF
|
$88.16 | -- | -- | -- | $0.03 | 0.09% | -- |
|
XPH
State Street SPDR S&P Pharmaceuticals ETF
|
$54.09 | -- | -- | -- | $0.10 | 0.94% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
PJP
Invesco Pharmaceuticals ETF
|
-- | 0.316 | -- | -- |
|
FBT
First Trust NYSE Arca Biotechnology Index Fund
|
-- | 0.657 | -- | -- |
|
PBE
Invesco Biotechnology & Genome ETF
|
-- | 0.859 | -- | -- |
|
RSPH
Invesco S&P 500 Eql Wght Health Care ETF
|
-- | 0.671 | -- | -- |
|
XHE
State Street SPDR S&P Health Care Equipment ETF
|
-- | 1.031 | -- | -- |
|
XPH
State Street SPDR S&P Pharmaceuticals ETF
|
-- | 0.588 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
PJP
Invesco Pharmaceuticals ETF
|
-- | -- | -- | -- | -- | -- |
|
FBT
First Trust NYSE Arca Biotechnology Index Fund
|
-- | -- | -- | -- | -- | -- |
|
PBE
Invesco Biotechnology & Genome ETF
|
-- | -- | -- | -- | -- | -- |
|
RSPH
Invesco S&P 500 Eql Wght Health Care ETF
|
-- | -- | -- | -- | -- | -- |
|
XHE
State Street SPDR S&P Health Care Equipment ETF
|
-- | -- | -- | -- | -- | -- |
|
XPH
State Street SPDR S&P Pharmaceuticals ETF
|
-- | -- | -- | -- | -- | -- |
Invesco Pharmaceuticals ETF vs. Competitors
-
Which has Higher Returns PJP or FBT?
First Trust NYSE Arca Biotechnology Index Fund has a net margin of -- compared to Invesco Pharmaceuticals ETF's net margin of --. Invesco Pharmaceuticals ETF's return on equity of -- beat First Trust NYSE Arca Biotechnology Index Fund's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital PJPInvesco Pharmaceuticals ETF-- -- -- FBTFirst Trust NYSE Arca Biotechnology Index Fund-- -- -- -
What do Analysts Say About PJP or FBT?
Invesco Pharmaceuticals ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand First Trust NYSE Arca Biotechnology Index Fund has an analysts' consensus of -- which suggests that it could fall by --. Given that Invesco Pharmaceuticals ETF has higher upside potential than First Trust NYSE Arca Biotechnology Index Fund, analysts believe Invesco Pharmaceuticals ETF is more attractive than First Trust NYSE Arca Biotechnology Index Fund.
Company Buy Ratings Hold Ratings Sell Ratings PJPInvesco Pharmaceuticals ETF0 0 0 FBTFirst Trust NYSE Arca Biotechnology Index Fund0 0 0 -
Is PJP or FBT More Risky?
Invesco Pharmaceuticals ETF has a beta of 0.506, which suggesting that the stock is 49.387% less volatile than S&P 500. In comparison First Trust NYSE Arca Biotechnology Index Fund has a beta of 0.724, suggesting its less volatile than the S&P 500 by 27.562%.
-
Which is a Better Dividend Stock PJP or FBT?
Invesco Pharmaceuticals ETF has a quarterly dividend of $0.24 per share corresponding to a yield of 0.95%. First Trust NYSE Arca Biotechnology Index Fund offers a yield of 0.55% to investors and pays a quarterly dividend of $1.17 per share. Invesco Pharmaceuticals ETF pays -- of its earnings as a dividend. First Trust NYSE Arca Biotechnology Index Fund pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios PJP or FBT?
Invesco Pharmaceuticals ETF quarterly revenues are --, which are smaller than First Trust NYSE Arca Biotechnology Index Fund quarterly revenues of --. Invesco Pharmaceuticals ETF's net income of -- is lower than First Trust NYSE Arca Biotechnology Index Fund's net income of --. Notably, Invesco Pharmaceuticals ETF's price-to-earnings ratio is -- while First Trust NYSE Arca Biotechnology Index Fund's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Invesco Pharmaceuticals ETF is -- versus -- for First Trust NYSE Arca Biotechnology Index Fund. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PJPInvesco Pharmaceuticals ETF-- -- -- -- FBTFirst Trust NYSE Arca Biotechnology Index Fund-- -- -- --
-
Which has Higher Returns PJP or PBE?
Invesco Biotechnology & Genome ETF has a net margin of -- compared to Invesco Pharmaceuticals ETF's net margin of --. Invesco Pharmaceuticals ETF's return on equity of -- beat Invesco Biotechnology & Genome ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital PJPInvesco Pharmaceuticals ETF-- -- -- PBEInvesco Biotechnology & Genome ETF-- -- -- -
What do Analysts Say About PJP or PBE?
Invesco Pharmaceuticals ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Invesco Biotechnology & Genome ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Invesco Pharmaceuticals ETF has higher upside potential than Invesco Biotechnology & Genome ETF, analysts believe Invesco Pharmaceuticals ETF is more attractive than Invesco Biotechnology & Genome ETF.
Company Buy Ratings Hold Ratings Sell Ratings PJPInvesco Pharmaceuticals ETF0 0 0 PBEInvesco Biotechnology & Genome ETF0 0 0 -
Is PJP or PBE More Risky?
Invesco Pharmaceuticals ETF has a beta of 0.506, which suggesting that the stock is 49.387% less volatile than S&P 500. In comparison Invesco Biotechnology & Genome ETF has a beta of 0.822, suggesting its less volatile than the S&P 500 by 17.787%.
-
Which is a Better Dividend Stock PJP or PBE?
Invesco Pharmaceuticals ETF has a quarterly dividend of $0.24 per share corresponding to a yield of 0.95%. Invesco Biotechnology & Genome ETF offers a yield of 0.49% to investors and pays a quarterly dividend of $0.23 per share. Invesco Pharmaceuticals ETF pays -- of its earnings as a dividend. Invesco Biotechnology & Genome ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios PJP or PBE?
Invesco Pharmaceuticals ETF quarterly revenues are --, which are smaller than Invesco Biotechnology & Genome ETF quarterly revenues of --. Invesco Pharmaceuticals ETF's net income of -- is lower than Invesco Biotechnology & Genome ETF's net income of --. Notably, Invesco Pharmaceuticals ETF's price-to-earnings ratio is -- while Invesco Biotechnology & Genome ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Invesco Pharmaceuticals ETF is -- versus -- for Invesco Biotechnology & Genome ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PJPInvesco Pharmaceuticals ETF-- -- -- -- PBEInvesco Biotechnology & Genome ETF-- -- -- --
-
Which has Higher Returns PJP or RSPH?
Invesco S&P 500 Eql Wght Health Care ETF has a net margin of -- compared to Invesco Pharmaceuticals ETF's net margin of --. Invesco Pharmaceuticals ETF's return on equity of -- beat Invesco S&P 500 Eql Wght Health Care ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital PJPInvesco Pharmaceuticals ETF-- -- -- RSPHInvesco S&P 500 Eql Wght Health Care ETF-- -- -- -
What do Analysts Say About PJP or RSPH?
Invesco Pharmaceuticals ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Invesco S&P 500 Eql Wght Health Care ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Invesco Pharmaceuticals ETF has higher upside potential than Invesco S&P 500 Eql Wght Health Care ETF, analysts believe Invesco Pharmaceuticals ETF is more attractive than Invesco S&P 500 Eql Wght Health Care ETF.
Company Buy Ratings Hold Ratings Sell Ratings PJPInvesco Pharmaceuticals ETF0 0 0 RSPHInvesco S&P 500 Eql Wght Health Care ETF0 0 0 -
Is PJP or RSPH More Risky?
Invesco Pharmaceuticals ETF has a beta of 0.506, which suggesting that the stock is 49.387% less volatile than S&P 500. In comparison Invesco S&P 500 Eql Wght Health Care ETF has a beta of 0.923, suggesting its less volatile than the S&P 500 by 7.663%.
-
Which is a Better Dividend Stock PJP or RSPH?
Invesco Pharmaceuticals ETF has a quarterly dividend of $0.24 per share corresponding to a yield of 0.95%. Invesco S&P 500 Eql Wght Health Care ETF offers a yield of 0.71% to investors and pays a quarterly dividend of $0.06 per share. Invesco Pharmaceuticals ETF pays -- of its earnings as a dividend. Invesco S&P 500 Eql Wght Health Care ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios PJP or RSPH?
Invesco Pharmaceuticals ETF quarterly revenues are --, which are smaller than Invesco S&P 500 Eql Wght Health Care ETF quarterly revenues of --. Invesco Pharmaceuticals ETF's net income of -- is lower than Invesco S&P 500 Eql Wght Health Care ETF's net income of --. Notably, Invesco Pharmaceuticals ETF's price-to-earnings ratio is -- while Invesco S&P 500 Eql Wght Health Care ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Invesco Pharmaceuticals ETF is -- versus -- for Invesco S&P 500 Eql Wght Health Care ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PJPInvesco Pharmaceuticals ETF-- -- -- -- RSPHInvesco S&P 500 Eql Wght Health Care ETF-- -- -- --
-
Which has Higher Returns PJP or XHE?
State Street SPDR S&P Health Care Equipment ETF has a net margin of -- compared to Invesco Pharmaceuticals ETF's net margin of --. Invesco Pharmaceuticals ETF's return on equity of -- beat State Street SPDR S&P Health Care Equipment ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital PJPInvesco Pharmaceuticals ETF-- -- -- XHEState Street SPDR S&P Health Care Equipment ETF-- -- -- -
What do Analysts Say About PJP or XHE?
Invesco Pharmaceuticals ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand State Street SPDR S&P Health Care Equipment ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Invesco Pharmaceuticals ETF has higher upside potential than State Street SPDR S&P Health Care Equipment ETF, analysts believe Invesco Pharmaceuticals ETF is more attractive than State Street SPDR S&P Health Care Equipment ETF.
Company Buy Ratings Hold Ratings Sell Ratings PJPInvesco Pharmaceuticals ETF0 0 0 XHEState Street SPDR S&P Health Care Equipment ETF0 0 0 -
Is PJP or XHE More Risky?
Invesco Pharmaceuticals ETF has a beta of 0.506, which suggesting that the stock is 49.387% less volatile than S&P 500. In comparison State Street SPDR S&P Health Care Equipment ETF has a beta of 1.125, suggesting its more volatile than the S&P 500 by 12.522%.
-
Which is a Better Dividend Stock PJP or XHE?
Invesco Pharmaceuticals ETF has a quarterly dividend of $0.24 per share corresponding to a yield of 0.95%. State Street SPDR S&P Health Care Equipment ETF offers a yield of 0.09% to investors and pays a quarterly dividend of $0.03 per share. Invesco Pharmaceuticals ETF pays -- of its earnings as a dividend. State Street SPDR S&P Health Care Equipment ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios PJP or XHE?
Invesco Pharmaceuticals ETF quarterly revenues are --, which are smaller than State Street SPDR S&P Health Care Equipment ETF quarterly revenues of --. Invesco Pharmaceuticals ETF's net income of -- is lower than State Street SPDR S&P Health Care Equipment ETF's net income of --. Notably, Invesco Pharmaceuticals ETF's price-to-earnings ratio is -- while State Street SPDR S&P Health Care Equipment ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Invesco Pharmaceuticals ETF is -- versus -- for State Street SPDR S&P Health Care Equipment ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PJPInvesco Pharmaceuticals ETF-- -- -- -- XHEState Street SPDR S&P Health Care Equipment ETF-- -- -- --
-
Which has Higher Returns PJP or XPH?
State Street SPDR S&P Pharmaceuticals ETF has a net margin of -- compared to Invesco Pharmaceuticals ETF's net margin of --. Invesco Pharmaceuticals ETF's return on equity of -- beat State Street SPDR S&P Pharmaceuticals ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital PJPInvesco Pharmaceuticals ETF-- -- -- XPHState Street SPDR S&P Pharmaceuticals ETF-- -- -- -
What do Analysts Say About PJP or XPH?
Invesco Pharmaceuticals ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand State Street SPDR S&P Pharmaceuticals ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Invesco Pharmaceuticals ETF has higher upside potential than State Street SPDR S&P Pharmaceuticals ETF, analysts believe Invesco Pharmaceuticals ETF is more attractive than State Street SPDR S&P Pharmaceuticals ETF.
Company Buy Ratings Hold Ratings Sell Ratings PJPInvesco Pharmaceuticals ETF0 0 0 XPHState Street SPDR S&P Pharmaceuticals ETF0 0 0 -
Is PJP or XPH More Risky?
Invesco Pharmaceuticals ETF has a beta of 0.506, which suggesting that the stock is 49.387% less volatile than S&P 500. In comparison State Street SPDR S&P Pharmaceuticals ETF has a beta of 0.657, suggesting its less volatile than the S&P 500 by 34.268%.
-
Which is a Better Dividend Stock PJP or XPH?
Invesco Pharmaceuticals ETF has a quarterly dividend of $0.24 per share corresponding to a yield of 0.95%. State Street SPDR S&P Pharmaceuticals ETF offers a yield of 0.94% to investors and pays a quarterly dividend of $0.10 per share. Invesco Pharmaceuticals ETF pays -- of its earnings as a dividend. State Street SPDR S&P Pharmaceuticals ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios PJP or XPH?
Invesco Pharmaceuticals ETF quarterly revenues are --, which are smaller than State Street SPDR S&P Pharmaceuticals ETF quarterly revenues of --. Invesco Pharmaceuticals ETF's net income of -- is lower than State Street SPDR S&P Pharmaceuticals ETF's net income of --. Notably, Invesco Pharmaceuticals ETF's price-to-earnings ratio is -- while State Street SPDR S&P Pharmaceuticals ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Invesco Pharmaceuticals ETF is -- versus -- for State Street SPDR S&P Pharmaceuticals ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PJPInvesco Pharmaceuticals ETF-- -- -- -- XPHState Street SPDR S&P Pharmaceuticals ETF-- -- -- --
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Google Vs NVIDIA Stock: Which Is Best?
Alphabet (NASDAQ:GOOGL) and NVIDIA (NASDAQ:NVIDIA) are two of the market’s…
How High Could NVIDIA Stock Go?
NVIDIA (NASDAQ:NVDA) has been one of the best stocks to…
Stock Ideas
Sell
50
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 61x
Buy
61
Is AAPL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 38x
Buy
63
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 40x
Alerts
Sell
39
PSTG alert for Dec 5
Pure Storage, Inc. [PSTG] is up 5.05% over the past day.
Sell
38
HOV alert for Dec 5
Hovnanian Enterprises, Inc. [HOV] is down 22.58% over the past day.
Buy
69
ASTS alert for Dec 5
AST Spacemobile, Inc. [ASTS] is up 18.25% over the past day.
